Ellie Kincaid is an editor at Retraction Watch. Her work has appeared in STAT, The Wall Street Journal, Forbes, WebMD and Medscape. She has a B.A. in English from Washington University in St. Louis and an M.A. in journalism from New York University’s Science, Health and Environmental Reporting Program.
Ellie Kincaid
Editor
Retraction Watch
From this contributor
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read
Head of company that accredits autism service providers resigns after article retraction
The resignation follows reporting by Spectrum and Retraction Watch in October about nonexistent references in the retracted article.
Head of company that accredits autism service providers resigns after article retraction
By
Ellie Kincaid
29 November 2023 | 4 min read
Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Article defending private-equity involvement in autism services retracted
By
Ellie Kincaid, Retraction Watch
19 October 2023 | 5 min read
Explore more from The Transmitter
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read
‘Friction-maxxing’ in school: Students should read primary literature, not AI summaries
Trainees need to learn how to identify a neuroscience paper’s major takeaways and integrate them into their understanding. This skill doesn’t come from outsourcing the work to large language models.
‘Friction-maxxing’ in school: Students should read primary literature, not AI summaries
Trainees need to learn how to identify a neuroscience paper’s major takeaways and integrate them into their understanding. This skill doesn’t come from outsourcing the work to large language models.
By
Nora Bradford
26 March 2026 | 5 min read